Stock Forecast
As of Fri Nov 27 2020 23:32:48 GMT+0000 (Coordinated Universal Time) shares of CP1 CANNPAL ANIMAL THERAPEUTICS LIMITED 0 percentage change in price since the previous day's close. Around 564070 of 93125000 changed hand on the market. The Stock opened at 0.14 with high and low of 0.13 and 0.14 respectively. The price/earnings ratio is: - and earning per share is -0.02. The stock quoted a 52 week high and low of 0.07 and 0.2 respectively.
BOSTON (AI Forecast Terminal) Fri, Nov 27, '20 AI Forecast today took the forecast actions: In the context of stock price realization of CP1 CANNPAL ANIMAL THERAPEUTICS LIMITED is a decision making process between multiple investors each of which controls a subset of design variables and seeks to minimize its cost function subject to future forecast constraints. That is, investors act like players in a game; they cooperate to achieve a set of overall goals.Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. Machine Learning based technical analysis (n+1y) for CP1 CANNPAL ANIMAL THERAPEUTICS LIMITED as below:
CP1 CANNPAL ANIMAL THERAPEUTICS LIMITED Credit Rating Overview
We rerate CP1 CANNPAL ANIMAL THERAPEUTICS LIMITED because the liabilities' resolution-driven default is unlikely because of all of the following: The type of liability is earmarked in the resolution framework for potential exclusion from bail-in at the discretion of the national regulator, other creditors in our view are unlikely to legally challenge such an exclusion. We use econometric methods for period (n+1y) simulate with Relative Strength Index (RSI) Spearman Correlation. Reference code is: 3854. Beta DRL value REG 34 Rational Demand Factor LD 5271.9786. Shared facilities with captive finance entities. When an issuer has a shared revolving credit facility with a captive finance entity, for purposes of calculating the issuer's liquidity sources, we net outstanding commercial paper at the captive from the revolver's borrowing availability. In these cases, we generally use an estimate of peak CP borrowings at the captive to avoid potentially overstating sources available to the issuer over a 12- to 24-month period. Credit Rating AI Process rely on primary sources of information: Sec Filings, Financial Statements, Credit Ratings, Semantic Signals. Take a look at Machine Learning section for Financial Deep Reinforcement Learning.
Oscillators are used for generating credit risk signals by using the semantic and financial signals. The value of the oscillators indicate the strength of trend. Using the correlation matrices, the risk map for CP1 CANNPAL ANIMAL THERAPEUTICS LIMITED as below:
Frequently Asked Questions
Q: What is CP1 CANNPAL ANIMAL THERAPEUTICS LIMITED stock symbol?A: CP1 CANNPAL ANIMAL THERAPEUTICS LIMITED stock referred as ASX:CP1
Q: What is CP1 CANNPAL ANIMAL THERAPEUTICS LIMITED stock price?
A: On share of CP1 CANNPAL ANIMAL THERAPEUTICS LIMITED stock can currently be purchased for approximately 0.14
Q: Do analysts recommend investors buy shares of CP1 CANNPAL ANIMAL THERAPEUTICS LIMITED ?
A: Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. View Machine Learning based technical analysis for CP1 CANNPAL ANIMAL THERAPEUTICS LIMITED at daily forecast section
Q: What is the earning per share of CP1 CANNPAL ANIMAL THERAPEUTICS LIMITED ?
A: The earning per share of CP1 CANNPAL ANIMAL THERAPEUTICS LIMITED is -0.02
Q: What is the market capitalization of CP1 CANNPAL ANIMAL THERAPEUTICS LIMITED ?
A: The market capitalization of CP1 CANNPAL ANIMAL THERAPEUTICS LIMITED is 12571875
